Evidence map›Paper›PMID 34156642›Full record

ReviewMolecular biotechnology2021

Strategies to Increase the Production of Biosynthetic Riboflavin.

Guiling Zhao, Fanyi Dong, Xingzhen Lao, Heng Zheng

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Riboflavin production by lactic acid bacteria: a mini-review.World journal of microbiology & biotechnology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Kinetics of Riboflavin Production byInternational journal of molecular sciences · 2024
    Article
  10. Changes of Active Substances inMolecules (Basel, Switzerland) · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Correlation between Dietary Intake of Vitamins and Oral Health Behaviors: A Cross-Sectional Study.International journal of environmental research and public health · 2023
    Article
  16. Metabolic Engineering ofMicroorganisms · 2023
    Review
  17. The Molecular Mechanism of Yellow Mushroom (Frontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Guiling ZhaoSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.
Fanyi DongSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.
Xingzhen LaoSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, People's Republic of China. lao@cpu.edu.cn.
Heng ZhengSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, People's Republic of China. zhengh18@hotmail.com.ORCID http://orcid.org/0000-0002-1810-5842
China Pharmaceutical University · CN

Funding

Priority Academic Program Development of Jiangsu Higher Education Institutions No. PPZY2015A057
6 · The paper itself

Abstract

Riboflavin is widely regarded as an essential nutrient that is involved in biological oxidation in vivo. In addition to preventing and treating acyl-CoA dehydrogenase deficiency in patients with keratitis, stomatitis, and glossitis, riboflavin is also closely related to the treatment of radiation mucositis and cardiovascular disease. Chemical synthesis has been the dominant method for producing riboflavin for approximately 50 years. Nevertheless, due to the intricate synthesis process, relatively high cost, and high risk of pollution, alternative methods of chemical syntheses, such as the fermentation method, began to develop and eventually became the main methods for producing riboflavin. At present, there are three types of strains used in industrial riboflavin production: Ashbya gossypii, Candida famata, and Bacillus subtilis. Additionally, many recent studies have been conducted on Escherichia coli and Lactobacillus. Fermentation increases the yield of riboflavin using genetic engineering technology to modify and induce riboflavin production in the strain, as well as to regulate the metabolic flux of the purine pathway and pentose phosphate pathway (PP pathway), thereby optimizing the culture process. This article briefly introduces recent progress in the fermentation of riboflavin.

Indexed as

BacteriaBatch Cell Culture TechniquesFermentationFungiGenetic EngineeringHumansPentose Phosphate PathwayPurinesRiboflavinPurinesRiboflavinAshbya gossypiiCandida famataGenetic modificationPentose phosphate pathwayPurine pathway

Identifiers

PMID34156642
OpenAlexW3174505565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.